Jinhai Medical Technology Limited (HKG:2225)

Revenue by Segment

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Services	16.31M	24.31M	25.21M	21.62M	20.34M
Services Growth	-32.91%	-3.57%	16.60%	6.33%	-9.50%
Products	29.96M	25.93M	20.43M	656.00K	1.56M
Products Growth	15.57%	26.90%	3014.48%	-57.90%	-
Total	46.28M	50.24M	45.64M	22.28M	21.90M
Total Growth	-7.89%	10.07%	104.87%	1.75%	-2.56%

Revenue by Geography

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
The People's Republic of China ("The PRC")	29.99M	25.93M	20.43M	656.00K	-
The People's Republic of China ("The PRC") Growth	15.67%	26.90%	3014.48%	-	-
Singapore	13.36M	15.90M	16.60M	21.62M	20.34M
Singapore Growth	-15.92%	-4.24%	-23.24%	6.33%	-9.50%
Unallocated	2.92M	8.42M	8.62M	-	-
Unallocated Growth	-65.28%	-2.28%	-	-	-
Mainland China	-	-	-	-	1.56M
Total	46.28M	50.24M	45.64M	22.28M	21.90M
Total Growth	-7.89%	10.07%	104.87%	1.75%	-2.56%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error